Home » Topics » BioWorld Science

BioWorld Science
RSS

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

FDA grants fast track designation to Debio-1347

May 8, 2018

Carna collaborates with Evotec to accelerate development of CB-1763

May 8, 2018

Polaris Pharmaceuticals creates new ADI-TRAIL fusion protein with antitumor activity

May 8, 2018

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

May 8, 2018

Takeda and Shire reach agreement on recommended offer for Shire

May 8, 2018

New trial explores use of AMO-01 in Phelan-McDermid syndrome

May 8, 2018

Aptose exercises option to license CrystalGenomics' CG-806

May 8, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...